ArticleBMC genomics2012
Comparison and evaluation of pathway-level aggregation methods of gene expression data.
Article in BMC genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome.NPJ genomic medicine · 2023Article
- Neurodevelopmental disorders and cancer networks share pathways; but differ in mechanisms, signaling strength, and outcome.bioRxiv : the preprint server for biology · 2023Article
- Statistical Inference for High-Dimensional Pathway Analysis with Multiple Responses.Computational statistics & data analysis · 2022Article
- Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer.International journal of molecular sciences · 2022Review
- UniPath: a uniform approach for pathway and gene-set based analysis of heterogeneity in single-cell epigenome and transcriptome profiles.Nucleic acids research · 2021Article
- System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation.International journal of molecular sciences · 2020Article
- Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.Cancer cell · 2020Article
- Dynamically characterizing individual clinical change by the steady state of disease-associated pathway.BMC bioinformatics · 2019Article
- Predictive modelling using pathway scores: robustness and significance of pathway collections.BMC bioinformatics · 2019Article
- Comparison of MetaMap and cTAKES for entity extraction in clinical notes.BMC medical informatics and decision making · 2018Article
- A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.Interface focus · 2018Article
- Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.Cancer · 2016Article
- In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.International journal of molecular sciences · 2014Article
- Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.Frontiers in genetics · 2014Article
- Multivariate inference of pathway activity in host immunity and response to therapeutics.Nucleic acids research · 2014Article
- Advances in translational bioinformatics and population genomics in the Asia-Pacific.BMC genomics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicroarray experiments produce expression measurements in genomic scale. A way to derive functional understanding of the data is to focus on functional sets of genes, such as pathways, instead of individual genes. While a common practice for the pathway-level analysis has been functional enrichment analysis such as over-representation analysis and gene set enrichment analysis, an alternative approach has also been explored. In this approach, gene expression data are first aggregated at pathway level to transform the original data into a compact representation in which each row corresponds to a pathway instead of a gene. Thereafter the pathway expression data can be used for differential expression and classification analyses in pathway space, leveraging existing algorithms usually applied to gene expression data. While several studies have proposed the pathway-level aggregation methods, it remains unclear how they compare with one another, since the evaluations were done to a limited extent. Thus this study presents a comprehensive evaluation of six most prominent aggregation methods.
resultsThe compared methods include five existing methods--mean of all member genes (Mean all), mean of condition-responsive genes (Mean CORGs), analysis of sample set enrichment scores (ASSESS), principal component analysis (PCA), and partial least squares (PLS)--and a variant of an existing method (Mean top 50%, averaging top half of member genes). Comprehensive and stringent benchmarking was performed by collecting seven pairs of related but independent datasets encompassing various phenotypes. Aggregation was done in the space of KEGG pathways. Performance of the methods was assessed by classification accuracy validated both internally and externally, and by examining the correlative extent of pathway signatures between the dataset pairs. The assessment revealed that (i) the best accuracy and correlation were obtained from ASSESS and Mean top 50%, (ii) Mean all showed the lowest accuracy, and (iii) Mean CORGs and PLS gave rise to the largest extent of discordance in the pathway signature correlation.
conclusionsThe two best performing method (ASSESS and Mean top 50%) are suggested to be preferred. The benchmarking analysis also suggests that there is both room and necessity for developing a novel method for pathway-level aggregation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.